Amicogene and Korea Institute of Ceramic Technology Partner to Develop Ligand for AAV Vector Purification
Amicogene and Korea Institute of Ceramic Technology Collaborate to Develop AAV Vector Purification Ligand Seoul, South Korea – Amicogene, led by CEO Park Cheol, and the Korea Institute of Ceramic Technology announced a partnership on the 18th to develop a cutting-edge ligand for the purification of Adenovirus-associated virus (AAV) vectors. By leveraging Amicogene’s expertise in […]
Gene Therapy Holds Promise for Reducing Alcohol Addiction and Drinking
New Research Shows Potential for Gene Therapy in Treating Alcohol Addiction Chronic alcoholism and the Impact on Dopamine Release A recent study has revealed that the brains of chronic alcoholics exhibit reduced dopamine release, which contributes to heavy drinking habits. This finding has significant implications for addiction treatment, as maintaining abstinence is a major challenge […]
Samjin Pharmaceutical and Epibiotech Partner for Joint Research on Antibody and Gene Therapy Technologies
Samjin Pharmaceutical Signs MOU with Epibiotech for Antibody and Gene Therapy Development In an exciting collaboration, Samjin Pharmaceutical, led by CEO Choi Yong-joo, has announced a strategic partnership with Epibiotech, a renowned research and development company specializing in cutting-edge hair loss treatments. This partnership aims to advance the development of antibody-drug conjugates (ADC) and gene […]
Genecore’s TarGET Platform Leads the Way in Developing Gene Therapy for Rare Genetic Diseases
**Genecore Selected for National New Drug Development Project for Huntington’s Disease Gene Therapy** Genecore, a leading biotech company, has recently announced its selection for the National New Drug Development Project 2023 Active Substances Phase research program. This project, facilitated by the National New Drug Development Agency (KDDF), aims to develop innovative treatments for rare genetic […]
